A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours

Horsley, L, Cummings, J, Middleton, M, Ward, T, Backen, A, Clamp, A, Dawson, M, Farmer, H, Fisher, N, Halbert, G, Halford, S, Harris, A, Hasan, J, Hogg, P, Kumaran, G, Little, R, Parker, GJM, Potter, P, Saunders, M, Roberts, C, Shaw, D, Smith, N, Smythe, J, Taylor, A, Turner, H, Watson, Y, Dive, C and Jayson, GC (2013) A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours CANCER CHEMOTHERAPY AND PHARMACOLOGY, 72 (6). pp. 1343-1352.

Full text not available from this repository.

Item Type:	Article
Authors :	Name Email ORCID Horsley, L UNSPECIFIED UNSPECIFIED Cummings, J UNSPECIFIED UNSPECIFIED Middleton, M UNSPECIFIED UNSPECIFIED Ward, T UNSPECIFIED UNSPECIFIED Backen, A UNSPECIFIED UNSPECIFIED Clamp, A UNSPECIFIED UNSPECIFIED Dawson, M UNSPECIFIED UNSPECIFIED Farmer, H UNSPECIFIED UNSPECIFIED Fisher, N UNSPECIFIED UNSPECIFIED Halbert, G UNSPECIFIED UNSPECIFIED Halford, S UNSPECIFIED UNSPECIFIED Harris, A UNSPECIFIED UNSPECIFIED Hasan, J UNSPECIFIED UNSPECIFIED Hogg, P UNSPECIFIED UNSPECIFIED Kumaran, G UNSPECIFIED UNSPECIFIED Little, R UNSPECIFIED UNSPECIFIED Parker, GJM UNSPECIFIED UNSPECIFIED Potter, P UNSPECIFIED UNSPECIFIED Saunders, M UNSPECIFIED UNSPECIFIED Roberts, C UNSPECIFIED UNSPECIFIED Shaw, D UNSPECIFIED UNSPECIFIED Smith, N UNSPECIFIED UNSPECIFIED Smythe, J UNSPECIFIED UNSPECIFIED Taylor, A a.taylor@surrey.ac.uk UNSPECIFIED Turner, H UNSPECIFIED UNSPECIFIED Watson, Y UNSPECIFIED UNSPECIFIED Dive, C UNSPECIFIED UNSPECIFIED Jayson, GC UNSPECIFIED UNSPECIFIED
Date :	1 December 2013
Identification Number :	https://doi.org/10.1007/s00280-013-2320-9
Uncontrolled Keywords :	Science & Technology, Life Sciences & Biomedicine, Oncology, Pharmacology & Pharmacy, ONCOLOGY, PHARMACOLOGY & PHARMACY, Phase 1, GSAO, Novel arsenic compound, Clinical trial, DCE-MRI, ACUTE PROMYELOCYTIC LEUKEMIA, APOPTOSIS PROTEIN XIAP, X-LINKED INHIBITOR, ARSENIC TRIOXIDE, CLINICAL-EFFICACY, ANGIOGENESIS INHIBITOR, METABOLISM INHIBITORS, CANCER-THERAPY, CELL-DEATH, VALIDATION
Related URLs :	Author
Depositing User :	Symplectic Elements
Date Deposited :	17 May 2017 10:02
Last Modified :	17 May 2017 14:46
URI:	http://epubs.surrey.ac.uk/id/eprint/826145

Actions (login required)

View Item

Downloads